Live feed16:34:10·120dINSIDERFilingvia QuantisnowChief Scientific Officer Betz Stephen F. was granted 30,000 shares, increasing direct ownership by 25% to 147,713 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.CRNX· Crinetics Pharmaceuticals Inc.Health CareOriginal source
